Your account is not claimed yet. You can sign up with ORCID to claim your account.

Tyler R McCaw

Years Active: 2018-2021
Publications (10 Years): 5

Biogen Idec Inc

North Carolina State University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Biogen Idec Inc

United States

Engineer I :: Technical Development

Education History

North Carolina State University

United States

BSC :: Engineering; Molecular and Structural Biochemistry

Publications

Tyler R McCaw, Evelyn Inga, Herbert Chen, Renata Jaskula-Sztul, Vikas Dudeja, James A Bibb, Bin Ren, J Bart Rose
Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance. The oncologist 26 (4) (2021)
Meagan M Jenkins, Tyler R McCaw, Paul A Goepfert
Mechanistic inferences from clinical reports of SARS-CoV-2. Infectious diseases (London, England) 52 (8) (2020)
Tyler R McCaw, Nidhi Goel, Dewey J Brooke, Ashwini A Katre, Angelina I Londoño, Haller J Smith, Troy D Randall, Rebecca C Arend
Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer. Cancer medicine 10 (2) (2020)
Tyler R McCaw, Mei Li, Dmytro Starenki, Mingyong Liu, Sara J Cooper, Rebecca C Arend, Andres Forero, Donald J Buchsbaum, Troy D Randall
Histone deacetylase inhibition promotes intratumoral CD8+ T-cell responses, sensitizing murine breast tumors to anti-PD1. Cancer immunology, immunotherapy : CII 68 (12) (2019)
Tyler R McCaw, Mei Li, Dmytro Starenki, Sara J Cooper, Mingyong Liu, Selene Meza-Perez, Rebecca C Arend, Donald J Buchsbaum, Andres Forero, Troy D Randall
The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth. Cancer immunology, immunotherapy : CII 68 (2) (2018)

Tyler R McCaw.css-eqlu8i{font-size:small;padding-left:4px;}